This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
Thanks to all who help keep JohnsonAndToxin ad-free, online and me working to expose Johnson & Johnson and their 275+ subsidiaries for the benefit of every man, woman and child on the planet - and that INCLUDES YOU and the ones YOU love.
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
Keywords: xarelto, death, dead, lawsuit, fda, litigation, bleed, aspirin
Date Created/Edited: September 4, 2017
I first wrote about Xarelto back in May of 2012. At that time, I stated that I thought Xarelto was another overhyped dud. I have definitely been proven correct. My closing paragraph sums up what I thought about Xarelto at that time...
"Missing data, 12% dropout rate (or lost track of) and three deaths should be a sure sign that J&J knows there are issues with the drug. In addition, the expectation of such a large number of recipients to total over a billion in sales, although the drug should not be prescribed to those under 18, over 65, anyone with high blood pressure, etc, as well as the known and published side effects - um, how, exactly, could this be a 'blockbuster'? What I see is more off-label marketing to meet sales goals and more harm with resulting lawsuits. Oh, joy. Higher health care costs to pay for yet another 'blockbuster'. More like 'economy buster'."A recently published article by Matthew Herper in Forbes explains that Johnson & Johnson wants to push KNOWN HARMFUL Xarelto through the FDA for additional indications - to increase sales by over $1.5 BILLION healthcare dollars. Has everyone at Johnson & Johnson and the United States Food and Drug Administration lost their minds?
Most notable about article is:
the 27,395-person trial specifically recruited patients who didn't need these other drugs, and whose disease was stable.and this...
Bleeding occurred in three patients out of every hundred in the Xarelto plus aspirin arm of the trial, a 70% increase compared to aspirin alone...
So, um, they studied only those who don't need drugs because their disease is stable and there is a 70% increase in bleeding. Doesn't sound like a big deal? Hm....
Johnson & Johnson has already been accused of false marketing for Xarelto - with over 20,000 lawsuits filed as of second quarter 2017 10-Q.
In 2016 alone there were over 15,000 adverse events including approximately 2,000 DEAD from use of Xarelto. That is the equivalent of FIVE PEOPLE DEAD FROM XARELTO EVERY SINGLE DAY. That's a whole lot of bodies, and that is the count only in the United States - with uncountable more bodies dropping from Xarelto in the other 129 countries where it is also sold.
And now these FREAKS at $JNJ $BAYR want to INCREASE VICTIMS?
As with the original Xarelto trials where the people that DIED were kicked out of study, United States Food and Drug Administration decision will be based solely on a hand-picked subgroup that show some possible benefit, maybe since subgroup already had condition under control, and um, weren't one of the ones that DIED from Xarelto during the study.
I don't know about you, but I cannot understand how a drug that KILLS FIVE PEOPLE A DAY is still on the market let alone even considered for MORE PEOPLE!
1. Emily Patterson (2012, May 23) Xarelto by Johnson & Johnson is Likely Another OverHyped Dud. JohnsonAndToxin Retrieved from http://www.johnsonandtoxin.com/xarelto.shtml
2. Matthew Herper (2017, August 27) New Data Could Add $1.5 Billion To Sales Of Johnson & Johnson Blood Thinner. Forbes Retrieved from https://www.forbes.com/sites/matthewherper/2017/08/27/new-data-could-add-1-5-billion-to-sales-of-johnson-johnsonbayer-blood-thinner/
3. Emily Patterson (2014, September 14) Johnson & Johnson Xarelto, False Marketing, Lawsuits and FDA Says THREE TIMES, "NO EXPANDED USES!". JohnsonAndToxin Retrieved from http://www.johnsonandtoxin.com/xarelto_continued.shtml
4. Emily Patterson (2017, August 8) Second Quarter 2017 Lawsuits Against Johnson & Johnson Stable, BUT NOT All-Inclusive. JohnsonAndToxin Retrieved from http://www.johnsonandtoxin.com/2017_second_quarter_lawsuits.shtml
5. Mark Annick (2017, July 25) More than 15,000 Adverse Events Linked to Xarelto in 2016. PR Newswire Retrieved from https://finance.yahoo.com/news/report-more-15-000-adverse-183800856.html